iFAST Diagnostics develops high-throughput antimicrobial susceptibility testing technology using microchip technology to rapidly analyze bacterial samples and combat antimicrobial resistance.

Aquark Technologies develops high-performing, magnetic field-free cold atom traps to enhance the accuracy and resilience of critical infrastructure against GPS jamming.

SOLASTA Bio develops peptide-based, nature-inspired bioinsecticides as sustainable alternatives to synthetic chemicals in the insecticide market.

Laverock Therapeutics is a UK-based biotech company that develops a gene silencing platform for advanced human therapeutic applications, with a focus on regenerative medicine and immuno-oncology.